PAPER Murphy C, Solomon ES, Haase L, Wang M, Morgan CD

Olfaction in aging and Alzheimer's disease: event-related potentials to a cross-modal odor-recognition memory task discriminate ApoE epsilon4+ and ApoE epsilon 4- individuals.

Ann N Y Acad Sci. 2009 Jul;1170:647-57. PubMed: 19686207

PAPER Gilbert PE, Pirogovsky E, Brushfield AM, Luu TT, Tolentino JC, Renteria AF

Age-related changes in associative learning for olfactory and visual stimuli in rodents.

Ann N Y Acad Sci. 2009 Jul;1170:718-24. PubMed: 19686218

PAPER Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA

Olfactory impairment in presymptomatic Alzheimer's disease.

Ann N Y Acad Sci. 2009 Jul;1170:730-5. PubMed: 19686220

PAPER Duffy CJ

Visual motion processing in aging and Alzheimer's disease: neuronal mechanisms and behavior from monkeys to man.

Ann N Y Acad Sci. 2009 Jul;1170:736-44. PubMed: 19686221

PAPER Sanchez-Ortiz E, Hahm BK, Armstrong DL, Rossie S

Protein phosphatase 5 protects neurons against amyloid-beta toxicity.

J Neurochem. 2009 Oct;111(2):391-402. PubMed: 19686245

PAPER Hossain S, Hashimoto M, Katakura M, Miwa K, Shimada T, Shido O

Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells.

J Neurochem. 2009 Oct;111(2):568-79. PubMed: 19686246

PAPER Miller Y, Ma B, Nussinov R

Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformation.

Biophys J. 2009 Aug 19;97(4):1168-77. PubMed: 19686665

PAPER Kotermanski SE, Wood JT, Johnson JW

Memantine binding to a superficial site on NMDA receptors contributes to partial trapping.

J Physiol. 2009 Oct 1;587(Pt 19):4589-604. PubMed: 19687120

PAPER Robert A, Gélinas I, Mazer B

Occupational therapists use of cognitive interventions for clients with Alzheimer's disease.

Occup Ther Int. 2010 Mar;17(1):10-9. PubMed: 19688778

PAPER Gies C, Lessick M

Alzheimer disease in women: a clinical and genetics perspective.

Nurs Womens Health. 2009 Aug;13(4):312-23; quiz 324. PubMed: 19686554

PAPER Huysseune S, Kienlen-Campard P, Hébert S, Tasiaux B, Leroy K, Devuyst O, Brion JP, De Strooper B, Octave JN

Epigenetic control of aquaporin 1 expression by the amyloid precursor protein.

FASEB J. 2009 Dec;23(12):4158-67. PubMed: 19687153

PAPER Landreth GE, Reed-Geaghan EG

Toll-like receptors in Alzheimer's disease.

Curr Top Microbiol Immunol. 2009;336:137-53. PubMed: 19688332

Akt1

ANTIBODY polyclonal manufacturer Cat# ab47432 Immunogen = synthetic non-phosphopeptide derived from human AKT1 around the phosphorylation site of threonine 308 liquid, PBS, azide, glycerol, affinity purified detects endogenous levels of total AKT1 protein IgG Akt

Akt1 phos T450

ANTIBODY polyclonal manufacturer Cat# ab58471 immunogen = synthetic phosphopeptide derived from human AKT1 around the phosphorylation site of threonine 450 (T I Tp P P) liquid, PBS, glycerol, NaCl, azide, affinity purified detects endogenous levels of AKT1 only wh

Akt1 phos S473 (EP2109Y)

ANTIBODY monoclonal EP2109Y manufacturer Cat# ab81283 immunogen = phospho specific peptide corresp. to residues surrounding Ser473 of human AKT1 liquid, glycerol, supernatant, tris-glycine saline, BSA, azide, affinity purified detects AKT1 phosphorylated at Serine